Previous 10 | Next 10 |
NeuroMetrix, Inc. (NURO) Q2 2020 Earnings Conference Call July 23, 2020, 8:00 am ET Company Participants Thomas Higgins - SVP & CFO Shai Gozani - President & CEO Conference Call Participants Presentation Operator Good morning and welcome to the NeuroMetrix Sec...
NeuroMetrix (NASDAQ: NURO ) : Q2 net loss of $0.9M More news on: NeuroMetrix, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
WOBURN, Mass., July 23, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended June 30, 2020. The Company is a leading developer of neurostimulation-based medical devices that are used to diagnose and treat chronic he...
WOBURN, Mass., July 16, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2020 second quarter financial results before the opening of the market on Thursday, July 23, 2020. The Company will host a conference call at 8:00 a.m., Eastern Time o...
WOBURN, Mass., July 09, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced expanded distribution in China for DPNCheck, a fast, accurate and quantitative nerve conduction test for evaluation of peripheral neuropathies such as diabetic peripheral neuropathy (DPN). D...
Milestone Scientific (NYSEMKT: MLSS ) -20% after pricing equity offering. More news on: Milestone Scientific Inc., DBV Technologies S.A., Ideanomics, Inc., Stocks on the move, , Read more ...
Nano cap NeuroMetrix ( NURO +7.2% ) inks an agreement with Biomedix to comarket its DPNCheck device for peripheral neuropathy detection in the Medicare Advantage and other value-based care markets. More news on: NeuroMetrix, Inc., Healthcare stocks news, Stocks on the move,...
WOBURN, Mass., June 25, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported that it has signed a collaboration agreement with Biomedix to comarket DPNCheck for peripheral neuropathy detection within Medicare Advantage and other value-based care markets. NeuroMetrix and ...
4 Penny Stocks Trading Under $2.50 Right Now What are penny stocks ? This is a great question if you’re new to trade small-cap and micro-cap stocks . Based on the traditional definition of penny stocks , these are shares of public companies trading for less than $5. While there may b...
WOBURN, Mass., June 10, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that it has launched a marketing initiative focusing on chronic knee pain. This effort includes direct-to-consumer digital marketing as well as informing physicians and other health ...
News, Short Squeeze, Breakout and More Instantly...
WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported financial and business highlights for the quarter ended March 31, 2024. The Company's mission is to reduce the impact of neurological disorders and pain syndromes through innovative non-invasive medica...
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
Apartment Investment and Management Company (AIV) is expected to report for Q1 2024 Shopify Inc. Class A Subordinate (SHOP) is expected to report $0.08 for Q1 2024 Beyond Meat Inc. (BYND) is expected to report $-0.68 for Q1 2024 Instructure Holdings Inc. (INST) is expected to report $...